Bensali, Ashyana S.
HRN: 27-82-43 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/20/2025
09/27/2025
IV
300mg
Q6H
PCAP D
Checking Initial Appropriateness
09/21/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
09/21/2025
09/28/2025
IV
23mg
Q24H
PCAP-D
Waiting Final Action
09/26/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
09/26/2025
10/03/2025
IV
50mg
Q12
PCAP
Checking Initial Appropriateness
09/27/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/27/2025
10/03/2025
IV
50mg
Q8
T/C NEC
Checking Initial Appropriateness